Feld L G, Cachero S, Van Liew J B, Zamlauski-Tucker M, Noble B
Department of Pediatrics, State University of New York, Buffalo School of Medicine.
Hypertension. 1990 Nov;16(5):544-54. doi: 10.1161/01.hyp.16.5.544.
Rats of the spontaneously hypertensive strain develop kidney damage that resembles the nephropathy seen in some cases of human essential hypertension. Previous studies with a triple drug antihypertensive regimen indicated that proteinuria and glomerular histopathology in spontaneously hypertensive rats might develop despite long-term effective control of systemic blood pressure. To investigate further the relation between hypertension and kidney disease, a group of spontaneously hypertensive rats were treated with enalapril at 15 weeks of age. Blood pressure, protein excretion, and kidney function were measured in those rats at regular intervals during the next year and a half and were compared with untreated spontaneously hypertensive rats and the normotensive Wistar-Kyoto parent strain. Kidney tissue samples from all three groups, collected at autopsy, were stained by immunohistochemical and conventional methods to assess the relative severity and nature of kidney damage. Although enalapril therapy was completely effective in controlling the blood pressure of spontaneously hypertensive rats, it only postponed the onset of kidney disease. Enalapril-treated spontaneously hypertensive rats eventually exhibited albuminuria as severe as that found in hypertensive rats. Kidney vessel pathology was completely prevented with enalapril, but the abnormal accumulation of mononuclear cells in tubulointerstitial and periglomerular sites was the same as in untreated spontaneously hypertensive rats. We have concluded that elevated protein excretion in rats of the spontaneously hypertensive rat strain is not a secondary consequence of systemic hypertension. Structural abnormalities of renal vessels also do not appear to contribute significantly to the pathogenesis of albuminuria in spontaneously hypertensive rats. Other explanations must be sought to account for the close link between spontaneous hypertension and kidney damage in this animal model. The clear dissociation of kidney disease from systemic hypertension exhibited by spontaneously hypertensive rats may also be relevant for human disease.
自发性高血压品系的大鼠会出现肾脏损伤,这种损伤类似于人类某些原发性高血压病例中所见的肾病。先前使用三联药物抗高血压方案的研究表明,尽管长期有效控制了全身血压,但自发性高血压大鼠的蛋白尿和肾小球组织病理学仍可能会发展。为了进一步研究高血压与肾脏疾病之间的关系,一组15周龄的自发性高血压大鼠接受了依那普利治疗。在接下来的一年半时间里,定期测量这些大鼠的血压、蛋白质排泄和肾功能,并与未治疗的自发性高血压大鼠和血压正常的Wistar-Kyoto亲本品系进行比较。在尸检时收集所有三组的肾脏组织样本,通过免疫组织化学和传统方法进行染色,以评估肾脏损伤的相对严重程度和性质。尽管依那普利治疗在控制自发性高血压大鼠的血压方面完全有效,但它只是推迟了肾脏疾病的发作。接受依那普利治疗的自发性高血压大鼠最终出现了与高血压大鼠一样严重的蛋白尿。依那普利完全预防了肾脏血管病变,但肾小管间质和肾小球周围部位单核细胞的异常积聚与未治疗的自发性高血压大鼠相同。我们得出结论,自发性高血压大鼠品系中蛋白质排泄增加不是全身高血压的继发后果。肾血管的结构异常似乎也对自发性高血压大鼠蛋白尿的发病机制没有显著贡献。必须寻求其他解释来解释这种动物模型中自发性高血压与肾脏损伤之间的密切联系。自发性高血压大鼠所表现出的肾脏疾病与全身高血压的明显分离也可能与人类疾病有关。